Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
2013 · Nature · 628 citations
https://doi.org/10.1038/nature12744
K
Kathryn E. Stephenson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
7.5K
Citations
38
h-index
62
i10-index
Kathryn E. Stephenson is an academic researcher from Ragon Institute of MGH, MIT and Harvard. The author has contributed to research in topics: HIV Research and Treatment & SARS-CoV-2 and COVID-19 Research & HIV/AIDS drug development and treatment. The author has an h-index of 38, co-authored 88 publications.
ORCID: 0000-0002-3440-4105Papers by this author
worksHIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
2019 · Cell Host & Microbe · 182 citations
https://doi.org/10.1016/j.chom.2018.12.001
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
2022 · Nature Medicine · 132 citations
https://doi.org/10.1038/s41591-022-01815-1
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
2020 · Clinical Infectious Diseases · 120 citations
https://doi.org/10.1093/cid/ciaa1466
Sex Differences in Long COVID
2025 · JAMA Network Open · 69 citations
https://doi.org/10.1001/jamanetworkopen.2024.55430
2024 Update of the RECOVER-Adult Long COVID Research Index
2024 · JAMA · 52 citations
https://doi.org/10.1001/jama.2024.24184
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat